Search results for "Highlights"


 
Results 121 - 130 of about 379 for "Highlights".
Sort by: Relevance | Newest | Oldest

Lowering serum urate levels with allopurinol did not improve kidney outcomes in patients with type 1 diabetes

Randomized trial participants with type 1 diabetes and mild-to-moderate diabetic kidney disease who received allopurinol or placebo had similar estimated glomerular filtration rates after three years.
https://diabetes.acponline.org/archives/2020/07/10/1.htm
10 Jul 2020

DPP-4 inhibitors may be effective for some cases of inpatient hyperglycemia

A narrative review considered the available evidence on use of metformin, thiazolidinediones, sulfonylureas, sodium-glucose cotransporter-2 inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors in the hospital.
https://diabetes.acponline.org/archives/2020/06/12/1.htm
12 Jun 2020

Patients with late-onset type 1 diabetes commonly treated as having type 2 diabetes

An analysis of patients with insulin-treated diabetes found that 38% of those with late-onset type 1 diabetes did not receive insulin at diagnosis, nearly half of whom reported a type 2 diabetes diagnosis.
https://diabetes.acponline.org/archives/2019/05/10/3.htm
10 May 2019

Metformin associated with more long-term weight loss than lifestyle change in prediabetes patients

Other independent predictors of long-term weight loss included greater weight loss in the first year and older age, according to this follow-up analysis of the Diabetes Prevention Program.
https://diabetes.acponline.org/archives/2019/05/10/2.htm
10 May 2019

AHA issues statement on coronary artery disease management in patients with diabetes

The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
https://diabetes.acponline.org/archives/2020/05/08/1.htm
8 May 2020

Early subspecialist involvement led to reduced infections among inpatients with diabetes

Researchers studied an early intervention model in which an inpatient diabetes team electronically identified patients with hyperglycemia and aimed to provide bedside management within 24 hours of admission, compared with a referral-based consultation service.
https://diabetes.acponline.org/archives/2019/04/05/3.htm
5 Apr 2019

Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients

The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.
https://diabetes.acponline.org/archives/2019/03/08/2.htm
8 Mar 2019

Sulfonylureas not supported as second-line treatment for type 2 diabetes

Risk for major adverse cardiovascular events and all-cause mortality was higher when a sulfonylurea was added to metformin compared to other typical second- or third-line therapy options in a recent Danish study.
https://diabetes.acponline.org/archives/2020/04/10/1.htm
10 Apr 2020

SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.
https://diabetes.acponline.org/archives/2019/03/08/3.htm
8 Mar 2019

Glycemic control worse over time in type 2 patients who decline insulin, study finds

In adults with uncontrolled type 2 diabetes who initially declined insulin versus those who initially accepted, median time to an HbA1c level below 7.0% was 50 months versus 38 months.
https://diabetes.acponline.org/archives/2020/03/13/1.htm
13 Mar 2020

Result Page: Prev   8   9   10   11   12   13   14   15   16   17   Next